Loading…
Wednesday, January 22 • 9:15am - 10:00am
Enhance Populations for Clinical Trial Diversity

Sign up or log in to save this to your schedule and see who's attending!

  • Discuss FDA Guidance on enhancing the diversity of clinical trial populations — including eligibility criteria, enrollment practices, and trial designs as guidance for industry
  • Deep dive into recommendations such as enrichment, inclusive trial practices, and design, and methodological ways to bring in a wider range of patient populations
  • How to ensure the inclusion of diverse patients in clinical trial design

Speakers
avatar for Jovonni  R. Spinner, MPH, CHES

Jovonni R. Spinner, MPH, CHES

Senior Public Health Advisor, U.S. Food and Drug Administration, Office of Minority Health and Health Equity (OMHHE)
Ms. Jovonni Spinner is a public health strategist and thought leader with a deep passion for improving health equity across the lifespan through research, communication, multi-sector partnerships, and leadership coaching. She is known as a public health programming guru using her... Read More →


Wednesday January 22, 2020 9:15am - 10:00am